Bavarian Nordic to hold Capital Markets Days in February 2024
22 nov. 2023 12h00 HE
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in February 2024 for investors and analysts across Europe and the U.S. At...
Bavarian Nordic to hold Capital Markets Days in February 2024
22 nov. 2023 12h00 HE
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in February 2024 for investors and analysts across Europe and the U.S. At...
Bavarian Nordic offentliggør delårsregnskab for de første ni måneder af 2023
16 nov. 2023 01h37 HE
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 16. november 2023 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab for de første ni måneder af 2023 samt rapporterede på begivenheder for tredje kvartal 2023. ...
Bavarian Nordic Announces Interim Results for the First Nine Months of 2023
16 nov. 2023 01h37 HE
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and business progress for the third quarter of...
Bavarian Nordics mpox-vaccine anbefales til rutinemæssig brug i risikogrupper af de amerikanske sundhedsmyndigheders rådgivningskomité
25 oct. 2023 14h03 HE
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 25. oktober 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at den rådgivende vaccinekomité (ACIP) hos det det amerikanske center for infektionsforebyggelse og folkesundhed...
Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
25 oct. 2023 14h03 HE
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, October 25, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices...
Bavarian Nordic tildelt yderligere kontrakt om levering af koppevacciner til strategisk lager i EU
13 sept. 2023 05h33 HE
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. september 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået yderligere en kontrakt til en værdi af mere end EUR 11 mio. på levering af MVA-BN®...
Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve
13 sept. 2023 05h33 HE
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, September 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 million to supply its MVA-BN® smallpox...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
04 sept. 2023 08h06 HE
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 4. september 2023 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
04 sept. 2023 08h06 HE
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, September 4, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...